J Epidemiol Community Health

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Epidemiology and Community Health 2007;61:154-158; doi:10.1136/jech.2006.050955
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kivimäki, M.
Right arrow Articles by Vahtera, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kivimäki, M.
Right arrow Articles by Vahtera, J.
Topic Collections
Right arrowRelevant Article

RESEARCH REPORT

Organisational downsizing and increased use of psychotropic drugs among employees who remain in employment

Mika Kivimäki2, Teija Honkonen1, Kristian Wahlbeck3, Marko Elovainio3, Jaana Pentti1, Timo Klaukka4, Marianna Virtanen1, Jussi Vahtera1

1 Finnish Institute of Occupational Health, Helsinki, Finland
2 Department of Epidemiology and Public Health, University College London, London, UK
3 National Research and Development Centre for Health and Welfare, Helsinki, Finland
4 Social Insurance Institution, Helsinki, Finland

Correspondence to:
Correspondence to:
Professor M Kivimäki
Department of Epidemiology and Public Health, University College London, 1–19 Torrington Place, London WC1E 6BT, UK; mika.kivimaki{at}ttl.fi

Objective: Organisational downsizing is common in modern work life, but its effect on employees’ mental health is not known. The authors examined whether working in downsizing organisations predicts use of psychotropic drugs among employees who remain in employment.

Design, setting and participants: Prospective cohort study of municipal employees in Finland. 4783 employees worked in downsized units but kept their jobs after downsizing in 1993, 4271 employees lost their jobs during the downsizing, and 17 599 employees did not experience downsizing. The outcome was psychotropic drug prescriptions (antidepressants, anxiolytics and hypnotics) during 1994–2000 extracted from nationwide registers and linked to the data by means of each participant’s personal identification number.

Main results: After adjustment for predownsizing characteristics, employees who were exposed to downsizing but kept their jobs were at a higher risk of being prescribed psychotropic drugs (rate ratio 1.49, 95% CI 1.10 to 2.02 in men and 1.12, 95% CI 1.00 to 1.27 in women) than those not exposed to downsizing. The association of downsizing was strongest with hypnotics among the men and with anxiolytics among the women. An increased rate of psychotropic prescriptions after downsizing was also seen in male workers who lost their job (rate ratio 1.64, 95% CI 1.19 to 2.25).

Conclusions: The association between organisational downsizing and increased use of psychotropic drugs suggests that this managerial strategy may pose mental health risks among employees.


Keywords: downsizing; employees; mental health; psychotropic drugs; work stress


Relevant Article

In this issue
Carlos Alvarez-Dardet and John R Ashton
J Epidemiol Community Health 2007 61: 89. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Occup. Environ. Med.Home page
Downsizing really is bad for workers' mental health
Occup. Environ. Med., May 1, 2007; 64(5): 290 - 290.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.